Amgen Wraps Otezla Takeover — And Other Fallout From BMY's Celgene BuyInvestors Business Daily • 11/21/19
Amgen raises full-year guidance after closing $13.4 billion Otezla acquisitionMarket Watch • 11/21/19
Amgen Is Taking A $2.7 Billion Stake In A Chinese Biotech — Here's WhyInvestors Business Daily • 10/31/19
Amgen Inc. (AMGN) CEO Bob Bradway on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/30/19